Institution
McGill University
Also known as: Université McGill
- 40running trials
- 19closed trials
- 3researchers
- 300,568publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Active, not recruiting
Recruiting
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
Recruiting
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Recruiting
Not yet recruiting
Enrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Not yet recruiting
Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy
Active, not recruiting
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Active, not recruiting
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Parkinson disease2 recruiting
- Asthma1 recruiting
- Brain aneurysm1 recruiting
- Endometrial cancer1 recruiting
- Epilepsy1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Head and neck cancer1 recruiting
- High blood pressure1 recruiting
- Lewy body dementia1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple system atrophy1 recruiting
- Myotonic dystrophy1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
Completed
Completed
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Completed
Completed
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
Completed
Completed
Completed
Completed
Completed
Completed
LOWER: Lomitapide Observational Worldwide Evaluation Registry
Completed
Completed
Completed
Completed
Completed
Completed
Registry name variants (5)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
McGill University
Montreal, Quebec H3A 0G4
41 trials
McGill University Department of Oncology
Montreal, Quebec H2W 1S6
13 trials
McGill University - Dept. Oncology Clinical Research Program
Montreal, Quebec H4A 3J1
3 trials
Contact: Revolution Medicines Study Director
NCT06578247Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
McGill University - Dept. Oncology
Montreal, Quebec H2W 1S6
1 trial
McGill University; Montreal Neurological Institute; Neurological and Psychiatric
Montreal, Quebec H3A 2B4
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Alzheimer disease408 works · 1 trial
- Obesity171 works · 2 trials
- Parkinson disease157 works · 3 trials
- Stroke127 works · 1 trial
- HIV115 works · 0 trials
- Schizophrenia108 works · 1 trial
- Type 2 diabetes93 works · 2 trials
- Epilepsy88 works · 1 trial
- Mild cognitive impairment85 works · 0 trials
- Tuberculosis80 works · 0 trials
- Multiple sclerosis71 works · 1 trial
- Ovarian cancer65 works · 1 trial
- Asthma61 works · 1 trial
- Melanoma59 works · 1 trial
- Bipolar disorder53 works · 0 trials
- Atrial fibrillation51 works · 0 trials
- Deep vein thrombosis and pulmonary embolism49 works · 0 trials
- Systemic sclerosis (scleroderma)49 works · 0 trials
- Depression48 works · 0 trials
- Frontotemporal dementia46 works · 0 trials
- Autism45 works · 0 trials
- ALS (motor neurone disease)44 works · 0 trials
- Type 1 diabetes44 works · 2 trials
- COPD39 works · 0 trials
- Cervical cancer38 works · 1 trial
- Endometrial cancer37 works · 1 trial
- Coronary artery disease36 works · 0 trials
- Triple-negative breast cancer36 works · 1 trial
- Crohn's disease34 works · 0 trials
- Ulcerative colitis33 works · 0 trials
Institution data: ROR 01pxwe438 (CC0-1.0)Updated 15 Nov 2026